ARTICLE | Company News
Mutabilis infectious news
September 24, 2012 7:00 AM UTC
Mutabilis received €4 million ($5.2 million) from the EU's Seventh Framework Program (FP7) for Mutabilis' HIVINNOV consortium to develop antiretrovirals targeting HIV-cellular cofactors interactions t...